Stroke risk and COVID-19

Stroke is comparatively frequent among patients with COVID-19 and has devastating consequences across all ages. The interaction of older age, comorbid conditions, and severity of COVID-19 metabolic process symptoms are related to very elevated mortality. Acute vessel disease, significantly anaemia stroke, has emerged as a heavy complication of infection by the severe acute respiratory syndrome coronavirus a pair of, the etiologic agent of the Coronavirus disease‐2019.

  • Therapy for communication disorders
  • Psychological evaluation and treatment

Related Conference of Stroke risk and COVID-19

July 20-21, 2026

37th World Congress on Neurology and Neuroscience

Amsterdam, Netherlands
July 23-24, 2026

14th International Conference on Cannabis & Medicinal Research

Amsterdam, Netherlands
September 18-19, 2026

21st Annual Congress on Neuroscience

Dubai, UAE
November 16-17, 2026

8th World Brain Congress

Tokyo, Japan
November 23-24, 2026

16th Global Alzheimers Summit

Paris, France
November 24-25, 2026

38th World Conference on Neurology

Rome, Italy
December 16-17, 2026

12th International Conference on Brain Injury & Neuro Surgeons

Amsterdam, Netherlands
December 21-22, 2026

6th International Conference on Child Neurology

Paris, France
December 28-29, 2026

39th European Neurology Congress

Amsterdam, Netherlands
December 28-29, 2026

18th Global Neurologists Meeting on Neurology and Neurosurgery

Amsterdam, Netherlands
March 22-23, 2027

8th International Conference on Neurologists

Singapore City, Singapore
March 24-25, 2027

38th Conference on Clinical Neuroscience and Neurogenetics

Geneva, Switzerland

Stroke risk and COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in